109 related articles for article (PubMed ID: 23588372)
21. [Pathologic and molecular genetic study of anaplastic lymphoma kinase-positive large B-cell lymphoma].
Huang RF; CHEN G; GONG LP; LU LL
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):169-72. PubMed ID: 21575387
[TBL] [Abstract][Full Text] [Related]
22. Novel ALK fusion partners in lung cancer.
Iyevleva AG; Raskin GA; Tiurin VI; Sokolenko AP; Mitiushkina NV; Aleksakhina SN; Garifullina AR; Strelkova TN; Merkulov VO; Ivantsov AO; Kuligina ESh; Pozharisski KM; Togo AV; Imyanitov EN
Cancer Lett; 2015 Jun; 362(1):116-21. PubMed ID: 25813404
[TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
Amin HM; McDonnell TJ; Ma Y; Lin Q; Fujio Y; Kunisada K; Leventaki V; Das P; Rassidakis GZ; Cutler C; Medeiros LJ; Lai R
Oncogene; 2004 Jul; 23(32):5426-34. PubMed ID: 15184887
[TBL] [Abstract][Full Text] [Related]
24. Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation.
Perkins SL; Pickering D; Lowe EJ; Zwick D; Abromowitch M; Davenport G; Cairo MS; Sanger WG
Br J Haematol; 2005 Dec; 131(5):624-7. PubMed ID: 16351638
[TBL] [Abstract][Full Text] [Related]
25. Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report.
Nakayama R; Togashi Y; Baba S; Kaku Y; Teramoto Y; Sakurai T; Haga H; Takeuchi K
Diagn Pathol; 2018 May; 13(1):28. PubMed ID: 29747676
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements.
Shi M; Miron PM; Hutchinson L; Woda BA; Nath R; Cerny J; Yu H
Hum Pathol; 2011 Oct; 42(10):1562-7. PubMed ID: 21497367
[TBL] [Abstract][Full Text] [Related]
27. ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript.
Wang WY; Gu L; Liu WP; Li GD; Liu HJ; Ma ZG
Pathol Res Pract; 2011 Sep; 207(9):587-91. PubMed ID: 21855232
[TBL] [Abstract][Full Text] [Related]
28. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review.
Rudzki Z; Rucińska M; Jurczak W; Skotnicki AB; Maramorosz-Kurianowicz M; Mruk A; Piróg K; Utych G; Bodzioch P; Srebro-Stariczyk M; Włodarska I; Stachura J
Pol J Pathol; 2005; 56(1):37-45. PubMed ID: 15921012
[TBL] [Abstract][Full Text] [Related]
29. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.
Khoury JD; Medeiros LJ; Rassidakis GZ; Yared MA; Tsioli P; Leventaki V; Schmitt-Graeff A; Herling M; Amin HM; Lai R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3692-9. PubMed ID: 14506160
[TBL] [Abstract][Full Text] [Related]
30. Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.
Sattu K; Hochgräfe F; Wu J; Umapathy G; Schönherr C; Ruuth K; Chand D; Witek B; Fuchs J; Li PK; Hugosson F; Daly RJ; Palmer RH; Hallberg B
FEBS J; 2013 Nov; 280(21):5269-82. PubMed ID: 23889739
[TBL] [Abstract][Full Text] [Related]
31. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.
Chiarle R; Simmons WJ; Cai H; Dhall G; Zamo A; Raz R; Karras JG; Levy DE; Inghirami G
Nat Med; 2005 Jun; 11(6):623-9. PubMed ID: 15895073
[TBL] [Abstract][Full Text] [Related]
32. Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma.
Liang X; Branchford B; Greffe B; McGavran L; Carstens B; Meltesen L; Albano EA; Quinones R; Cook B; Graham DK
J Pediatr Hematol Oncol; 2013 Jul; 35(5):e209-13. PubMed ID: 23619105
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death.
Zamo A; Chiarle R; Piva R; Howes J; Fan Y; Chilosi M; Levy DE; Inghirami G
Oncogene; 2002 Feb; 21(7):1038-47. PubMed ID: 11850821
[TBL] [Abstract][Full Text] [Related]
34. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ
Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
[TBL] [Abstract][Full Text] [Related]
35. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R
Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340
[TBL] [Abstract][Full Text] [Related]
36. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24.
Stachurski D; Miron PM; Al-Homsi S; Hutchinson L; Harris NL; Woda B; Wang SA
Hum Pathol; 2007 Jun; 38(6):940-5. PubMed ID: 17509395
[TBL] [Abstract][Full Text] [Related]
38. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
Ladanyi M; Cavalchire G
Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682
[TBL] [Abstract][Full Text] [Related]
39. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.
Thompson MA; Stumph J; Henrickson SE; Rosenwald A; Wang Q; Olson S; Brandt SJ; Roberts J; Zhang X; Shyr Y; Kinney MC
Hum Pathol; 2005 May; 36(5):494-504. PubMed ID: 15948116
[TBL] [Abstract][Full Text] [Related]
40. ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression.
Baker J; Zadeh SL; Aguilera NS
J Hematop; 2024 Jun; 17(2):109-114. PubMed ID: 38573563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]